ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 410 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,073 | -8.6% | 625 | -0.8% | 0.01% | +25.0% |
| Q2 2023 | $42,740 | +25.5% | 630 | +0.3% | 0.01% | +14.3% |
| Q1 2023 | $34,069 | -6.7% | 628 | +3.1% | 0.01% | -12.5% |
| Q4 2022 | $36,516 | +30.4% | 609 | 0.0% | 0.01% | +14.3% |
| Q3 2022 | $28,000 | -17.6% | 609 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $34,000 | -20.9% | 609 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $43,000 | +7.5% | 609 | 0.0% | 0.01% | +11.1% |
| Q4 2021 | $40,000 | -13.0% | 609 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $46,000 | -4.2% | 609 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $48,000 | -4.0% | 609 | 0.0% | 0.01% | -8.3% |
| Q1 2021 | $50,000 | -2.0% | 609 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $51,000 | +27.5% | 609 | 0.0% | 0.01% | +7.7% |
| Q3 2020 | $40,000 | +5.3% | 609 | 0.0% | 0.01% | -13.3% |
| Q2 2020 | $38,000 | – | 609 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |